Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Pharmacogenet Genomics. 2022 Jan 1;32(1):1–9. doi: 10.1097/FPC.0000000000000445

Figure 2: The effect of rs34767465 on FAM114A2 gene and protein expression in LCLs.

Figure 2:

A) Relative gene expression of FAM114A2 by rs34767465 genotypes in LCLs (number of subjects per genotype group - WT = 62, Het = 24, Hom = 3).

B) Immunoblot gel image showing decreased FAM114A2 protein expression by rs34767465 genotypes. Three different LCL lines with known genotypes were used.

C) Quantitative analysis of immunoblotting results using Image J. Protein values are normalized by β-tubulin expression and are shown relative to WT expression.

Wild type-WT, Heterozygous-Het, Homozygous-Hom, LCL-Lymphoblastoid Cell lines.

* p<0.05 ** p<0.01.